These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 1284959
1. 4-(Aminomethyl)-1-aryl-2-pyrrolidinones, a new class of monoamine oxidase B inactivators. Ding CZ, Silverman RB. J Enzyme Inhib; 1992; 6(3):223-31. PubMed ID: 1284959 [Abstract] [Full Text] [Related]
2. Transformation of heterocyclic reversible monoamine oxidase-B inactivators into irreversible inactivators by N-methylation. Ding CZ, Silverman RB. J Med Chem; 1993 Nov 12; 36(23):3606-10. PubMed ID: 8246228 [Abstract] [Full Text] [Related]
5. Oxazolidinones, dihydrofuranones, and pyrrolidinones as inactivators and substrates of monoamine oxidase B: approaches to the design of antiparkinsonian agents. Silverman RB. Farmaco; 1997 May 12; 52(5):343-52. PubMed ID: 9274004 [No Abstract] [Full Text] [Related]
7. SAR studies of fluorine-substituted benzylamines and substituted 2-phenylethylamines as substrates and inactivators of monoamine oxidase B. Silverman RB, Hawe WP. J Enzyme Inhib; 1995 May 12; 9(3):203-15. PubMed ID: 8847600 [Abstract] [Full Text] [Related]
8. Transformation of monoamine oxidase-B primary amine substrates into time-dependent inhibitors. Tertiary amine homologues of primary amine substrates. Ding CZ, Lu X, Nishimura K, Silverman RB. J Med Chem; 1993 Jun 11; 36(12):1711-5. PubMed ID: 8510099 [Abstract] [Full Text] [Related]
9. Inactivation of monoamine oxidase B by analogues of the anticonvulsant agent milacemide (2-(n-pentylamino)acetamide). Nishimura K, Lu X, Silverman RB. J Med Chem; 1993 Feb 19; 36(4):446-8. PubMed ID: 8474100 [Abstract] [Full Text] [Related]
10. Synthesis of novel MPTP analogs as potential monoamine oxidase B (MAO-B) inhibitors. Kalgutkar AS, Castagnoli N. J Med Chem; 1992 Oct 30; 35(22):4165-74. PubMed ID: 1433219 [Abstract] [Full Text] [Related]
11. Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives. Chimenti F, Carradori S, Secci D, Bolasco A, Bizzarri B, Chimenti P, Granese A, Yáñez M, Orallo F. Eur J Med Chem; 2010 Feb 30; 45(2):800-4. PubMed ID: 19926363 [Abstract] [Full Text] [Related]
12. 2-Azolylchromone Derivatives as Potent and Selective Inhibitors of Monoamine Oxidases A and B. Takao K, Saito T, Chikuda D, Sugita Y. Chem Pharm Bull (Tokyo); 2016 Feb 30; 64(10):1499-1504. PubMed ID: 27725503 [Abstract] [Full Text] [Related]
13. Mechanism-based inactivation of monoamine oxidases A and B by tetrahydropyridines and dihydropyridines. Krueger MJ, McKeown K, Ramsay RR, Youngster SK, Singer TP. Biochem J; 1990 May 15; 268(1):219-24. PubMed ID: 2344359 [Abstract] [Full Text] [Related]
14. Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives. Palaska E, Aydin F, Uçar G, Erol D. Arch Pharm (Weinheim); 2008 Apr 15; 341(4):209-15. PubMed ID: 18266289 [Abstract] [Full Text] [Related]
15. The use of mechanism-based inactivators to probe the mechanism of monoamine oxidase. Silverman RB. Biochem Soc Trans; 1991 Feb 15; 19(1):201-6. PubMed ID: 2037149 [No Abstract] [Full Text] [Related]
16. A new time-dependent reversible inhibitor of monoamine oxidase. Williams CH, Brady JD, Lawson J. J Enzyme Inhib; 1996 Feb 15; 10(3):159-65. PubMed ID: 8835941 [No Abstract] [Full Text] [Related]
17. Imidazole bearing chalcones as a new class of monoamine oxidase inhibitors. Sasidharan R, Baek SC, Sreedharannair Leelabaiamma M, Kim H, Mathew B. Biomed Pharmacother; 2018 Oct 15; 106():8-13. PubMed ID: 29940538 [Abstract] [Full Text] [Related]
18. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives. Delogu G, Picciau C, Ferino G, Quezada E, Podda G, Uriarte E, Viña D. Eur J Med Chem; 2011 Apr 15; 46(4):1147-52. PubMed ID: 21316817 [Abstract] [Full Text] [Related]
19. Mechanism-based inhibition of monoamine oxidase by 3-aryl-Delta3-pyrrolines. Williams CH, Lawson J. Biochem J; 1998 Nov 15; 336 ( Pt 1)(Pt 1):63-7. PubMed ID: 9806885 [Abstract] [Full Text] [Related]